• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

所有小鼠造血干细胞亚群的骨髓和脾脏接种效率都会因预先与造血生长因子孵育而降低。

Marrow- and spleen-seeding efficiencies of all murine hematopoietic stem cell subsets are decreased by preincubation with hematopoietic growth factors.

作者信息

van der Loo J C, Ploemacher R E

机构信息

Institute of Hematology, Erasmus University Rotterdam, The Netherlands.

出版信息

Blood. 1995 May 1;85(9):2598-606.

PMID:7537121
Abstract

The cobblestone-area forming cell (CAFC) assay permits a direct measurement of the seeding of primitive and more mature murine hematopoietic stem cell subsets by comparing the number of CAFC in the original transplant with the number of CAFC retrieved from bone marrow (BM) and spleen after transplantation. We found no differences in seeding efficiency between the more mature and primitive CAFC subsets, nor between seeding efficiencies of stem cells from low-density (LD) fractions of normal and day-6 post-5-fluorouracil BM. The data show that 18% to 20% of all intravenously transplanted stem cell subsets seed to the BM, whereas 8% to 10% seed to the spleen. In addition, similar seeding efficiencies were found for day-12 spleen colony-forming unit (CFU-S-12) as was determined by retransplantation. Previously, it has been reported that a 2- to 3-hour preincubation of BM with interleukin-3 (IL-3) enhances the in vivo repopulating ability of a graft. To test whether hematopoietic growth factors affected this increased engraftment by enhancing the seeding of the transplanted marrow, we assessed the 16- to 18-hour seeding efficiency of short- and long-term in vivo repopulating stem cell subsets to BM and spleen using the CAFC assay, after preincubation with or without hematopoietic growth factors. A 2- to 3-hour preincubation with IL-3, or a combination of IL-3, IL-12, and steel factor, at 37 degrees C, led to a substantial decrease in seeding compared with control (which was kept on ice) of all hematopoietic subsets measured, both in spleen and BM. In concert with these data, the long-term in vivo repopulating ability of growth-factor incubated BM was also decreased when compared with control. In conclusion, we have been unable to observe a beneficial effect of growth factor preincubation on the repopulating ability of a graft.

摘要

鹅卵石区域形成细胞(CAFC)测定法通过比较原始移植中CAFC的数量与移植后从骨髓(BM)和脾脏中回收的CAFC数量,直接测量原始和更成熟的小鼠造血干细胞亚群的接种情况。我们发现,更成熟和原始的CAFC亚群之间的接种效率没有差异,正常和5-氟尿嘧啶处理后第6天的骨髓低密度(LD)组分中的干细胞接种效率之间也没有差异。数据显示,所有静脉内移植的干细胞亚群中有18%至20%接种到骨髓,而8%至10%接种到脾脏。此外,通过再移植确定,第12天脾集落形成单位(CFU-S-12)的接种效率相似。此前有报道称,用白细胞介素-3(IL-3)对骨髓进行2至3小时的预孵育可增强移植物的体内再填充能力。为了测试造血生长因子是否通过增强移植骨髓的接种来影响这种增加的植入,我们在有或没有造血生长因子预孵育后,使用CAFC测定法评估了短期和长期体内再填充干细胞亚群在16至18小时内接种到骨髓和脾脏的效率。在37℃下用IL-3或IL-3、IL-12和钢因子的组合进行2至3小时的预孵育,与对照(置于冰上)相比,所测量的所有造血亚群在脾脏和骨髓中的接种均显著减少。与这些数据一致,与对照相比,生长因子孵育的骨髓的长期体内再填充能力也降低了。总之,我们未能观察到生长因子预孵育对移植物再填充能力的有益影响。

相似文献

1
Marrow- and spleen-seeding efficiencies of all murine hematopoietic stem cell subsets are decreased by preincubation with hematopoietic growth factors.所有小鼠造血干细胞亚群的骨髓和脾脏接种效率都会因预先与造血生长因子孵育而降低。
Blood. 1995 May 1;85(9):2598-606.
2
Leukemia inhibitory factor upregulates cytokine expression by a murine stromal cell line enabling the maintenance of highly enriched competitive repopulating stem cells.白血病抑制因子通过一种小鼠基质细胞系上调细胞因子表达,从而维持高度富集的竞争性再增殖干细胞。
Blood. 1996 Jun 1;87(11):4618-28.
3
Identification of hematopoietic stem cell subsets on the basis of their primitiveness using antibody ER-MP12.使用抗体ER-MP12基于其原始性鉴定造血干细胞亚群。
Blood. 1995 Feb 15;85(4):952-62.
4
Transient and permanent engraftment potential of murine hematopoietic stem cell subsets: differential effects of host conditioning with gamma radiation and cytotoxic drugs.小鼠造血干细胞亚群的短暂和永久植入潜力:γ射线照射和细胞毒性药物对宿主预处理的不同影响。
Exp Hematol. 1993 Jul;21(7):913-21.
5
Interleukin-12 synergizes with interleukin-3 and steel factor to enhance recovery of murine hemopoietic stem cells in liquid culture.白细胞介素-12与白细胞介素-3和干细胞因子协同作用,以增强小鼠造血干细胞在液体培养中的恢复。
Leukemia. 1993 Sep;7(9):1381-8.
6
Stem cell factor increases colony-forming unit-spleen number in vitro in synergy with interleukin-6, and in vivo in Sl/Sld mice as a single factor.干细胞因子与白细胞介素-6协同作用时可在体外增加脾集落形成单位数量,而在Sl/Sld小鼠体内作为单一因子时也可增加脾集落形成单位数量。
Blood. 1992 Feb 15;79(4):913-9.
7
Seeding efficiency of primitive human hematopoietic cells in nonobese diabetic/severe combined immune deficiency mice: implications for stem cell frequency assessment.原始人类造血细胞在非肥胖糖尿病/严重联合免疫缺陷小鼠中的接种效率:对干细胞频率评估的意义
Blood. 1999 Nov 1;94(9):3055-61.
8
Ex vivo expansion of murine marrow cells with interleukin-3 (IL-3), IL-6, IL-11, and stem cell factor leads to impaired engraftment in irradiated hosts.用白细胞介素-3(IL-3)、白细胞介素-6(IL-6)、白细胞介素-11(IL-11)和干细胞因子对小鼠骨髓细胞进行体外扩增,会导致其在受辐照宿主中的植入受损。
Blood. 1996 Jan 1;87(1):30-7.
9
Restrictions in the stem cell function of murine bone marrow grafts after ex vivo expansion of short-term repopulating progenitors.短期再增殖祖细胞体外扩增后小鼠骨髓移植干细胞功能的限制
Exp Hematol. 1998 Feb;26(2):100-9.
10
Differential adherence of murine hematopoietic stem cell subsets to fibronectin.小鼠造血干细胞亚群对纤连蛋白的差异性黏附
Exp Hematol. 1994 Dec;22(13):1236-43.

引用本文的文献

1
Mapping Hematopoietic Fate after Transplantation.移植后造血命运图谱
Stem Cell Rev Rep. 2025 Aug 20. doi: 10.1007/s12015-025-10946-0.
2
Repurposing the prostaglandin analogue treprostinil and the calcium-sensing receptor modulator cinacalcet to revive cord blood as an alternate source of hematopoietic stem and progenitor cells for transplantation.重新利用前列腺素类似物曲前列尼尔和钙敏感受体调节剂西那卡塞,以使脐带血复苏,作为移植用造血干细胞和祖细胞的替代来源。
Front Pharmacol. 2025 Jan 9;15:1444311. doi: 10.3389/fphar.2024.1444311. eCollection 2024.
3
Mobilization-based engraftment of haematopoietic stem cells: a new perspective for chemotherapy-free gene therapy and transplantation.
动员造血干细胞植入:化疗-free 基因治疗和移植的新视角。
Br Med Bull. 2023 Sep 12;147(1):108-120. doi: 10.1093/bmb/ldad017.
4
Clinical Progress and Preclinical Insights Into Umbilical Cord Blood Transplantation Improvement.脐带血移植改进的临床进展和临床前见解。
Stem Cells Transl Med. 2022 Sep 21;11(9):912-926. doi: 10.1093/stcltm/szac056.
5
Differential CXCR4 expression on hematopoietic progenitor cells versus stem cells directs homing and engraftment.造血祖细胞与干细胞上 CXCR4 的差异表达指导归巢和植入。
JCI Insight. 2022 May 9;7(9):e151847. doi: 10.1172/jci.insight.151847.
6
Intrabone transplantation of CD34+ cells with optimized delivery does not enhance engraftment in a rhesus macaque model.经优化递送的 CD34+ 细胞的骨内移植不会增强恒河猴模型中的植入。
Blood Adv. 2020 Dec 22;4(24):6148-6156. doi: 10.1182/bloodadvances.2020003040.
7
Engineering the hematopoietic stem cell niche: Frontiers in biomaterial science.构建造血干细胞微环境:生物材料科学前沿
Biotechnol J. 2015 Oct;10(10):1529-45. doi: 10.1002/biot.201400758. Epub 2015 Sep 10.
8
Superselective intra-arterial umbilical cord blood administration to BM in experimental animals.在实验动物中对骨髓进行超选择性动脉内脐血输注。
Bone Marrow Transplant. 2014 Dec;49(12):1486-91. doi: 10.1038/bmt.2014.190. Epub 2014 Sep 8.
9
Intrabone transplant of cord blood stem cells establishes a local engraftment store: a functional PET/FDG study.脐血干细胞骨内移植建立局部植入储备:一项PET/FDG功能研究
J Biomed Biotechnol. 2012;2012:767369. doi: 10.1155/2012/767369. Epub 2012 Oct 2.
10
Current progress and challenges in HIV gene therapy.HIV基因治疗的当前进展与挑战。
Future Virol. 2011 Nov 1;6(11):1319-1328. doi: 10.2217/fvl.11.113.